Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081986 | SCV000113921 | benign | not specified | 2017-03-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081986 | SCV000517514 | benign | not specified | 2015-12-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001510536 | SCV001717598 | benign | ALG1-congenital disorder of glycosylation | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000081986 | SCV002500482 | benign | not specified | 2022-03-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001510536 | SCV002801161 | benign | ALG1-congenital disorder of glycosylation | 2022-04-08 | criteria provided, single submitter | clinical testing |